Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms 68Ga-NOTA-CTX001, 68Ga BOT1712, BOT 1712 + [1] |
Target |
Mechanism PDGFRβ modulators(Platelet-derived growth factor receptor beta modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis, Liver | Preclinical | NL | 30 Apr 2024 | |
Pulmonary Fibrosis | Preclinical | NL | 30 Apr 2024 | |
Colonic Cancer | Preclinical | NL | 31 Jul 2023 | |
Liver Cirrhosis | Preclinical | NL | 31 Jul 2023 |